科研速览 · Science Skim继续刷下去 · Keep skimming →
◆ Genes & Diseases2026-03-27· Medicine

The update of prostaglandin E2 receptor subtype 4 (EP4) in inflammatory diseases

Shuxuan Li, Tong Wang, Anran Niu, Yuyan Du, Dong Zhou, Liang Gao, Haining Zhou, Shengnan Du

原始摘要(英文原文)· Original abstract
Inflammation is a defensive response of the organism to stimuli and is crucial for maintaining the stability of the internal environment. However, abnormal inflammatory responses, including over-activation or hypo-responsiveness, are among the major factors causing numerous diseases. Among all prostaglandin substances, PGE 2 is one of the common lipid mediators produced by the catalysis of arachidonic acid (AA) by cyclooxygenase (COX). Through autocrine or paracrine secretion, PGE 2 acts on four receptor subtypes ( i.e. , EP1, EP2, EP3, and EP4) and participates in various physiological and pathophysiological processes, commonly including fever, pain, and inflammation. Among them, EP4 is deeply researched and mediates many effects of PGE 2 , such as fever, pain, inflammation, blood pressure regulation, water-salt metabolism, and tumorigenesis. In particular, the mechanism of action and potential therapeutic value of EP4 in inflammatory diseases have been research hotspots for years. Here, we summarize the function of the PGE 2 –EP4 signaling in inflammation and related inflammatory diseases.
读原文 · Read the paper ↗

AI 追问PRO

登录后使用 AI 追问

讨论区

登录后参与讨论

相关论文 · Related

The update of prostaglandin E2 receptor subtype 4 (EP4) in inflammatory diseases — 科研速览 Science Skim